Genome-wide gene-environment interaction analyses to understand the relationship between red meat and processed meat intake and colorectal cancer risk.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
19 Dec 2023
Historique:
accepted: 11 12 2023
received: 21 06 2023
revised: 05 09 2023
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: aheadofprint

Résumé

High red meat and/or processed meat consumption are established colorectal cancer (CRC) risk factors. We conducted a genome-wide gene-environment (GxE) interaction analysis to identify genetic variants that may modify these associations. A pooled sample of 29,842 CRC cases and 39,635 controls of European ancestry from 27 studies were included. Quantiles for red meat and processed meat intake were constructed from harmonized questionnaire data. Genotyping arrays were imputed to the Haplotype Reference Consortium. Two-step EDGE and joint tests of GxE interaction were utilized in our genome-wide scan. Meta-analyses confirmed positive associations between increased consumption of red meat and processed meat with CRC risk (per quartile red meat OR = 1.30; 95%CI = 1.21-1.41; processed meat OR = 1.40; 95%CI = 1.20-1.63). Two significant genome-wide GxE interactions for red meat consumption were found. Joint GxE tests revealed the rs4871179 SNP in chromosome 8 (downstream of HAS2); greater than median of consumption ORs = 1.38 (95%CI = 1.29-1.46), 1.20 (95%CI = 1.12 -1.27), and 1.07 (95%CI = 0.95 - 1.19) for CC, CG and GG, respectively. The two-step EDGE method identified the rs35352860 SNP in chromosome 18 (SMAD7 intron); greater than median of consumption ORs = 1.18 (95%CI = 1.11-1.24), 1.35 (95%CI = 1.26-1.44), and 1.46 (95%CI = 1.26-1.69) for CC, CT, and TT, respectively. We propose two novel biomarkers that support the role of meat consumption with an increased risk of CRC. The reported GxE interactions may explain the increased risk of CRC in certain population subgroups.

Sections du résumé

BACKGROUND BACKGROUND
High red meat and/or processed meat consumption are established colorectal cancer (CRC) risk factors. We conducted a genome-wide gene-environment (GxE) interaction analysis to identify genetic variants that may modify these associations.
METHODS METHODS
A pooled sample of 29,842 CRC cases and 39,635 controls of European ancestry from 27 studies were included. Quantiles for red meat and processed meat intake were constructed from harmonized questionnaire data. Genotyping arrays were imputed to the Haplotype Reference Consortium. Two-step EDGE and joint tests of GxE interaction were utilized in our genome-wide scan.
RESULTS RESULTS
Meta-analyses confirmed positive associations between increased consumption of red meat and processed meat with CRC risk (per quartile red meat OR = 1.30; 95%CI = 1.21-1.41; processed meat OR = 1.40; 95%CI = 1.20-1.63). Two significant genome-wide GxE interactions for red meat consumption were found. Joint GxE tests revealed the rs4871179 SNP in chromosome 8 (downstream of HAS2); greater than median of consumption ORs = 1.38 (95%CI = 1.29-1.46), 1.20 (95%CI = 1.12 -1.27), and 1.07 (95%CI = 0.95 - 1.19) for CC, CG and GG, respectively. The two-step EDGE method identified the rs35352860 SNP in chromosome 18 (SMAD7 intron); greater than median of consumption ORs = 1.18 (95%CI = 1.11-1.24), 1.35 (95%CI = 1.26-1.44), and 1.46 (95%CI = 1.26-1.69) for CC, CT, and TT, respectively.
CONCLUSIONS CONCLUSIONS
We propose two novel biomarkers that support the role of meat consumption with an increased risk of CRC.
IMPACT CONCLUSIONS
The reported GxE interactions may explain the increased risk of CRC in certain population subgroups.

Identifiants

pubmed: 38112776
pii: 731778
doi: 10.1158/1055-9965.EPI-23-0717
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Mariana C Stern (MC)

University of Southern California, Los Angeles, CA, United States.

Joel Sanchez Mendez (J)

University of Southern California, Los Angeles, United States.

Andre E Kim (AE)

University of Southern California, Los Angeles, CA, United States.

Mireia Obón-Santacana (M)

Institut d'Investigació Biomédica de Bellvitge, Barcelona, Spain.

Ferran Moratalla-Navarro (F)

Institut d'Investigació Biomédica de Bellvitge, Hopitalet de Llobregat, Barcelona, Spain.

Vicente Martín (V)

University of Leon, Leon, Leon, Spain.

Victor Moreno (V)

Catalan Institute of Oncology, Hopitalet de Llobregat, Barcelona, Spain.

Yi Lin (Y)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Stephanie A Bien (SA)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Conghui Qu (C)

Fred Hutchinson Cancer Center, United States.

Yu-Ru Su (YR)

Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.

Emily White (E)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Tabitha A Harrison (TA)

Fred Hutchinson Cancer Center, Seattle, United States.

Jeroen R Huyghe (JR)

Fred Hutchinson Cancer Center, Seattle, United States.

Catherine M Tangen (CM)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Polly A Newcomb (PA)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Amanda I Phipps (AI)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Claire E Thomas (CE)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Eric S Kawaguchi (ES)

University of Southern California, Los Angeles, CA, United States.

Juan Pablo Lewinger (JP)

University of Southern California, Los Angeles, CA, United States.

John L Morrison (JL)

University of Southern California, Los Angeles, CA, United States.

David V Conti (DV)

University of Southern California, Los Angeles, CA, United States.

Jun Wang (J)

University of Southern California, Los angeles, CA, United States.

Duncan C Thomas (DC)

USC Norris Cancer Hospital, Los Angeles, CA, United States.

Elizabeth A Platz (EA)

Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.

Kala Visvanathan (K)

Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.

Temitope O Keku (TO)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Christina C Newton (CC)

American Cancer Society, Atlanta, GA, United States.

Caroline Y Um (CY)

American Cancer Society, Kennesaw, GA, United States.

Anshul Kundaje (A)

Stanford University School of Medicine, Palo Alto, CA, United States.

Anna Shcherbina (A)

Stanford University, Stanford, United States.

Neil Murphy (N)

International Agency For Research On Cancer, Lyon, France.

Marc J Gunter (MJ)

International Agency For Research On Cancer, Lyon Cedex 08, France.

Niki Dimou (N)

International Agency For Research On Cancer, Lyon, France.

Nikos Papadimitriou (N)

International Agency For Research On Cancer, Lyon, France.

Stéphane Bézieau (S)

Centre Hospitalier Universitaire de Nantes, Nantes, France.

Fränzel Jb van Duijnhoven (FJ)

Wageningen University & Research, Wageningen, Netherlands.

Satu Männistö (S)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Gad Rennert (G)

Carmel Medical Center, Haifa, Israel.

Alicja Wolk (A)

Karolinska Institutet, Stockholm, Sweden.

Michael Hoffmeister (M)

German Cancer Research Center, Heidelberg, Germany.

Hermann Brenner (H)

German Cancer Research Center, Heidelberg, Germany.

Jenny Chang-Claude (J)

German Cancer Research Center, Heidelberg, Germany.

Yu Tian (Y)

Capital Medical University, Beijing, China.

Loïc Le Marchand (L)

University of Hawaii Cancer Center, Honolulu, Hawaii, United States.

Michelle Cotterchio (M)

Ontario Health, Toronto, Ontario, Canada.

Konstantinos K Tsilidis (KK)

University of Ioannina, Ioannina, Greece.

D Timothy Timothy Bishop (DTT)

University of Leeds, Leeds, West Yorkshire, United Kingdom.

Yohannes Adama Melaku (YA)

Cancer Council Victoria, Melbourne, Australia.

Brigid M Lynch (BM)

Cancer Council Victoria, East Melbourne, Victoria, Australia.

Daniel D Buchanan (DD)

University of Melbourne, Parkville, Victoria, Australia.

Cornelia M Ulrich (CM)

Huntsman Cancer Institute, Salt Lake City, UT, United States.

Jennifer Ose (J)

University of Utah, Salt Lake City, Utah, United States.

Anita R Peoples (AR)

University of Utah, Salt Lake City, Utah, United States.

Andrew J Pellatt (AJ)

The University of Texas MD Anderson Cancer Center, Houston, United States.

Li Li (L)

University of Virginia, Charlottesville, Virgina, United States.

Matthew Am Devall (MA)

University of Virginia, Charlottesville, United States.

Peter T Campbell (PT)

Albert Einstein College of Medicine, Bronx, NY, United States.

Demetrius Albanes (D)

National Cancer Institute, Bethesda, MD, United States.

Stephanie J Weinstein (SJ)

National Cancer Institute, Bethesda, MD, United States.

Sonja I Berndt (SI)

National Cancer Institute, Bethesda, MD, United States.

Stephen B Gruber (SB)

City Of Hope National Medical Center, Duarte, CA, United States.

Edward Ruiz-Narvaez (E)

University of Michigan-Ann Arbor, Ann Arbor, MI, United States.

Mingyang Song (M)

Harvard T.H. Chan School of Public Health, Boston, MA, United States.

Amit D Joshi (AD)

Massachusetts General Hospital and Harvard Medical School, Boston, United States.

David A Drew (DA)

University of Connecticut Health Center, Boston, MA, United States.

Jessica L Petrick (JL)

Boston University, Boston, MA, United States.

Andrew T Chan (AT)

Massachusetts General Hospital, Boston, MA, United States.

Marios Giannakis (M)

Dana-Farber Cancer Institute, Boston, MA, United States.

Ulrike Peters (U)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

Li Hsu (L)

Fred Hutchinson Cancer Center, Seattle, WA, United States.

W James Gauderman (WJ)

University of Southern California, Los Angeles, CA, United States.

Classifications MeSH